Literature DB >> 11092448

Redox modulation of the NMDA receptor.

Y B Choi1, S A Lipton.   

Abstract

Redox modulation has been recognized to be an important mechanism of regulation for the N-methyl-D-aspartate (NMDA) receptor. Sulfhydryl reducing agents enhance, whereas oxidizing agents decrease, NMDA-evoked currents. Multiple cysteine residues located in different NMDA receptor subunits have been identified as molecular determinants underlying redox modulation. The NMDA receptor is also regulated by nitric oxide (NO)-related species directly, not involving cyclic GMP, but the molecular mechanism of this action has heretofore not been entirely clear. The confusion arose at least partly due to the fact that various redox forms of NO (NO+, NO*, NO-, each having an additional electron compared with the previous) have distinct mechanisms of action. Recently, a critical cysteine residue (Cys 399) on the NR2A subunit has been shown to react under physiological conditions with NO by S-nitrosylation (transfer of the NO+ to cysteine thiol) or by reaction with NO- (nitroxyl anion) to underlie this form of modulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092448     DOI: 10.1007/pl00000638

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  42 in total

Review 1.  Redox regulation of mitochondrial function.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2012-02-03       Impact factor: 8.401

Review 2.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 3.  Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca2+ channels in senescent synaptic plasticity.

Authors:  Thomas C Foster
Journal:  Prog Neurobiol       Date:  2012-01-28       Impact factor: 11.685

4.  S-Nitrosoglutathione administration ameliorates cauda equina compression injury in rats.

Authors:  Anandakumar Shunmugavel; Mushfiquddin Khan; Marcus M Martin; Anne G Copay; Brian R Subach; Thomas C Schuler; Inderjit Singh
Journal:  Neurosci Med       Date:  2012-09-25

Review 5.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

6.  Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction.

Authors:  Aarron Phensy; Kathy L Lindquist; Karen A Lindquist; Dania Bairuty; Esha Gauba; Lan Guo; Jing Tian; Heng Du; Sven Kroener
Journal:  J Neurosci       Date:  2020-06-30       Impact factor: 6.167

Review 7.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

Review 8.  Specificity in S-nitrosylation: a short-range mechanism for NO signaling?

Authors:  Antonio Martínez-Ruiz; Inês M Araújo; Alicia Izquierdo-Álvarez; Pablo Hernansanz-Agustín; Santiago Lamas; Juan M Serrador
Journal:  Antioxid Redox Signal       Date:  2013-01-04       Impact factor: 8.401

Review 9.  Nitric oxide: promoter or suppressor of programmed cell death?

Authors:  Yiqin Wang; Chen Chen; Gary J Loake; Chengcai Chu
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

Review 10.  Mechanisms involved in the cerebrovascular dilator effects of N-methyl-d-aspartate in cerebral cortex.

Authors:  David W Busija; Ferenc Bari; Ferenc Domoki; Thomas Louis
Journal:  Brain Res Rev       Date:  2007-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.